Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	26.83	17.48	13.78
Graham Fair Price	27.88	40357.65	31559.44
PEG	-81.47	0.08	-0.45
Price/Book	-2.31	0.31	0.32
Price/Cash Flow	2869.27	-226.68	7.63
Prices/Earnings	-37.69	5.04	8.09
Price/Sales	2.23	1.23	1.20
Price/FCF	2869.27	-226.68	7.63
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	3.57	0.13	0.12
Operating Margin	-16.97	0.04	0.05
ROA	53.35	0.01	< 0.005
ROE	< 0.005	0.02	56.79
ROIC	0.01	< 0.005	-50.38
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.10	-0.19	-47.13
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	0.66	-0.19	-71.20
EPS QOQ	-0.18	0.60	236.24
FCF QOQ	24.26	-1.03	-95.74
Revenue QOQ	0.02	-0.02	11.19
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	83.78	91.35	9.03
Days Sales Outstanding (DSO)	96.62	103.28	6.89
Inventory Turnover	1.07	0.99	-8.28
Debt/Capitalization	0.12	0.13	6.73
Quick Ratio	1.53	1.52	-0.66
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	67120.23	68547.28	2.13
Cash	8220.59	9312.85	13.29
Capex	-524.32	-467.71	10.80
Free Cash Flow	2796.67	-93.97	-96.64
Revenue	17802.43	17372.75	-2.41
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.41	2.39	-0.73
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.19	2.55	114.70
Naive Interpretation	Member

06 - Financial Health · Bad

Rating